STAR Ph3 study with patients previously treated KRAS G12C-positive advanced or metastastatic NSCLC
Phase III Clinical Trial
A phase 3 randomized open-label multicenter study evaluating the efficacy and safety of divarasib versus sotorasib or adagrasib in patients with previously treated KRAS G12C-positive advanced or metastatic Non-Small Cell Lung Cancer (BO45217)